Search
Search Results
##search.searchResults.foundPlural##
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1238PDF: 714HTML: 308 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1933PDF: 802HTML: 213 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1792PDF: 791HTML: 3589 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3840PDF: 1466HTML: 8500 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2119PDF: 965HTML: 138Suppl. Files: 506 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2125PDF: 1447HTML: 258 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1021PDF: 956HTML: 317 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1354PDF: 675HTML: 1072Untitled: 175Untitled: 146Untitled: 126Untitled: 147Untitled: 157 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1182PDF: 705HTML: 1221 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2033PDF: 1033HTML: 15643COVER LETTER: 183 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
453PDF: 237HTML: 75 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4197PDF: 1510HTML: 440 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1508PDF: 775HTML: 1468Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 176 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
1999PDF: 781HTML: 1025 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3342PDF: 1284HTML: 1854Fig.1: 195Fig. 2: 198 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
713PDF: 463HTML: 6259 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
697PDF: 826PDF Supp. Files: 73HTML: 178
1 - 35 of 35 items







